glp 1 weight loss guidelines How GLP-1 Helps Support Lean Muscle Preservation The World Health Organization on

April 2024

The 2020 Standards of Medical Care include some notable updates related to patient-centered care and the use of glucose-lowering agents

Lee and Jun 2016)

Its important to note that GLP-1 injections are not recommended for individuals with certain thyroid conditions, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as well as for pregnant or breastfeeding women

Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver diseaseCurrent evidence

Following the promising results of the REWIND trial, FDA approved Trulicity (Dulaglutide) in those with T2DM who either have cardiovascular disease or are at increased risk of the disease to be used preventively for reduction in MACE [45]